|
| Home : Medical Marijuana, Inc. Investment AXIM(R) Biotechnologies, Inc. Secures Funding to Continue Pharma Clinical Trials Program in Cannabinoid R&D |
|
Oct 27
2016 |
Medical Marijuana, Inc. Investment AXIM(R) Biotechnologies, Inc. Secures Funding to Continue Pharma Clinical Trials Program in Cannabinoid R&D |
|
Financing Enables Cannabinoid Innovator to Continue Phase I-II Trials Of Numerous Intellectual Property (IP) Protected Cannabinoid-Based Products for Multiple Indications |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=2169899&sourceType=3 |
| |
|
Related News
|
» Funding to move to feasibility and discharge RMB debt obligations
» Karsten Energy Corp. Announces $120,000 Private Placement
|
|
|
